SPC211
Ríbóciclib eða lyfjafræðilega viðunandi salt þar af
Status:
VeittApplication date:
15.11.2017Application published:
15.12.2017Grant published:
15.5.2019
Max expiry date:
23.8.2032Medicine name:
KisqaliMedicine for children:
No
Timeline
Today
15.11.2017Application
15.12.2017Publication
15.5.2019Registration
23.8.2032Expires
Marketing license
IS authorization number:
EU/1/17/1221/001-012Date:
12.9.2017
Foreign authorization number:
EU/1/17/1221Date:
22.8.2017
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, Basel CH
Name:
Astex Therapeutics Ltd.Address:
436 Cambridge Science Park Milton Road, Cambridge CB4 0QA GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2331547